Technology

First H5N1 Influenza Vaccine Approved by FDA

February 3, 2020

An adjuvanted influenza A H5N1 monovalent vaccine (Audenz) has been approved by the US Food and Drug Administration (FDA). The approval was granted to Seqirus.